Exact Sciences ( EXAS ) Rides on Cologuard Sales, New Launches
Exact Sciences (EXAS) identifies more than 100 opportunities with payers and health systems to address the care gaps with Cologuard through screening programs.
| Ticker |
Sentiment |
Impact |
|
MASI
|
Neutral
|
17 %
|
|
DGX
|
Neutral
|
17 %
|
|
EXAS
|
Somewhat Bullish
|
42 %
|
|
BSX
|
Neutral
|
13 %
|
